Home NDC 70518-1614 acyclovir
Product NDC 70518-1614
11-digit product format 705181614
Labeler code 70518
Product ID 70518-1614_4e921ba6-8b1f-c638-e063-6394a90a61b8
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name acyclovir
Dosage form TABLET
Route ORAL
Labeler REMEDYREPACK INC.
Application ANDA204314
Marketing category ANDA
Marketing start 2018-10-29
Substance ACYCLOVIR
Active strength 800 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base acyclovir
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 800 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 197313
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70518-1614-0 acyclovir 30 in 1 BLISTER PACK TABLET 30 7
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70518-1614-0 70518161400 30 TABLET in 1 BLISTER PACK (70518-1614-0) 30 tablet 2018-10-29 No No Historical